A Clinical Update for the Treatment of Multiple Myeloma with Reduced Bone Complications

http://academiccme.com/wp-content/uploads/2017/09/iStock-497651790-wpcf_400x400.jpg

Course Information

Therapautic Area: Hematology, Oncology
Format(s): Webcast
Credit(s): 1.00 AMA PRA Category 1 Credit(s)™
Activity Dates: September 14, 2017 - September 13, 2018

 

Program Overview

This CME/CNE activity will include clinical updates for the treatment of Multiple Myeloma with reduced bone complications. Expert faculty will review the science of multiple myeloma, including disease course, patient assessment and comorbidities. The current head to head trial data for emerging therapeutics for the treatment of relapsed/refractory multiple myeloma will be analyzed. The faculty will guide clinicians on how to incorporate optimal treatment strategies into patient-specific plans to improve the overall survival in patients with multiple myeloma with reduced bone complications. Upon completing this activity, clinicians will gain knowledge on the most up-to-date care for this cohort of patients.

Target Audience

Hematologists/Oncologists, primary care physicians, nurse practitioners, and other healthcare professionals responsible for the treatment of Multiple Myeloma.

Learning Objectives

1. Identify the science of multiple myeloma, including disease course, patient assessment and comorbidities.
2. Analyze the current head to head trial data for emerging therapeutics for the treatment of relapsed/refractory multiple myeloma.
3. Incorporate optimal treatment strategies into patient-specific plans to improve the overall survival in patients with multiple myeloma with reduced bone complications.

Faculty


C Ola Landgren, MDC. Ola Landgren, MD, PhD
Chief of Myeloma Service
Memorial Sloan-Kettering Cancer Center
Professor of Medicine
Weill Cornell Medical College
New York, New York

 

Faiman_Headshot

Beth Faiman PhD, MSN, APN-BC, AOCN
Nurse Practitioner
Department of Hematologic Oncology
Cleveland Clinic Taussig Cancer Institute
Cleveland, Ohio

 

 

Niesvizky_Headshot

Ruben Niesvizky, MD
Professor of Medicine
Weill Cornell Medical College
Director, Multiple Myeloma Center and Oncology Operations
New York Presbyterian Hospital/Weill Cornell Medicine
New York, New York

 

 

Disclosures of Conflict of Interest

It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity.

Faculty Relationship Identified With:
C. Ola Landgren, MD, PhD Consultant/Advisor: Amgen Inc.; Merck & Co. Pharmaceutical Company; Millennium Pharmaceuticals, Inc.; Onyx Pharmaceuticals; Takeda Pharmaceuticals U.S.A., Inc.
Beth Faiman PhD, MSN, APN-BC, AOCN

 

Consultant/Advisor: Amgen Inc.; Bristol-Myers Squibb Company; Celgene Corporation; Takeda Pharmaceuticals U.S.A., Inc.

Speaker’s Bureau: Amgen Inc.; Bristol-Myers Squibb Company; Celgene Corporation; Takeda Pharmaceuticals U.S.A., Inc.

Ruben Niesvizky, MD Speaker’s Bureau: Amgen Inc.; Bristol-Myers Squibb Company; Celgene Corporation; Janssen Global Services, LLC; Takeda Pharmaceuticals U.S.A., Inc.

 

Planners, Managers, Reviewers

Timothy Hayes, MD, PhD; Emma Boring; Nicole Brestowski; Chelsey Benedek and Kim Cheramie, MSN, RN-BC hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.

Accreditation Statement

AcademicCME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AcademicCME is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation Statement

AcademicCME designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AcademicCME designates this enduring material for a maximum of 1.0 CNE contact hour (1.0 CNE pharmacotherapeutic contact hour).

Financial Support

This activity has been supported by an independent educational grant from Amgen Inc.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Amgen Inc. do not recommend the use of any agent outside of the labeled indications.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Method of Participation

In order to claim credit, participants must complete the following:

  1. Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
  2. Complete the Pre-Activity Questions
  3. Read or Review the activity content.
  4. Complete the Post-Activity Test Questions and Evaluation.
  5. Physicians who receive a grade of 70% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a CME Certificate.
  6. All other participants who receive a grade of 70% or better on the Post-Activity Test Questions and who complete the Evaluation will receive a Certificate of Participation.

CME/CNE Inquiries/Special Needs

For all CME inquiries or special needs, please contact admin@academiccme.com.
BUTTON


Provided by AcademicCME.

unnamed